1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6AD29CB04D2B801A085256EBC006B3900
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/fostering-cross-functional-portfolio-management?opendocument
18
19opendocument
203.82.52.91
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing New Product Development and Launch Managing Development Process Cross-Functional Teams Team Structure

Fostering Cross-Functional Portfolio Management

DB Image

ID: 4678


Features:


Pages/Slides: 14


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

While top-performing pharmaceutical companies recognize that innovative drug discovery depends upon a deep understanding of market needs and the research skill of top scientists working with state-of-the-art technologies, most companies commonly struggle with the decision to commit resources to a product that may or may not make it past the next phase. Pharmaceutical companies can benefit from this document’s findings on how to effectively create a marketplace focus throughout the development phase. This 14-page document discusses the use of cross-functional evaluation teams as a key factor in speeding up the product evaluation process.

Key Topics

  • The Importance of Cross-Functional Teams
  • Employing Cross-Functional Teams to Guide Product Development


Sample Best Practices
  • Create “checklists” to improve long-term results of business development.
    * A formalized process has been key one benchmark partner’s success as a research and marketing partner.
  • Involve new product planning personnel throughout the development process to maintain consistent support.
    * Another studied company involves its New Product Development personnel from day one of the product development process.
  • Identify critical success factors regarding licensing or co-promotions when interacting with internal departments
    * One company finds that hurdles to successful licensing and co-promotions are often found within the company.

Methodology
The insights and best practices showcased in this report are distilled from lessons learned in interviews with executives and specialists who have extensive experience in designing and managing new product planning and strategic alliance departments at a range of pharmaceutical companies. This document originated from a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
Eli Lilly; Pfizer; Amgen; Janssen


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.